Improving Access to Dementia Care in the Era of Monoclonal Antibody Treatments for Alzheimer’s Disease: a Pilot Clinical Protocol Using Abbreviated Neuropsychological Assessment
Implementing an abbreviated neuropsychological assessment process significantly reduced the time between referral and evaluation to identify individuals who may be eligible for emerging pharmacological treatments for AD and/or non-pharmacological interventions in a timely manner.
Authors
- Anelyssa D’Abreu (ORCID: https://orcid.org/0000-0001-6786-555X)
- Savana M. Naini (ORCID: https://orcid.org/0000-0002-6555-3234)
- Ryan C. Thompson (ORCID: https://orcid.org/0000-0002-0775-3166)
- Shannon Reilly (ORCID: https://orcid.org/0000-0003-2279-0595)
- Virginia T. Gallagher (ORCID: https://orcid.org/0000-0002-3526-0828)
- Carol A. Manning (ORCID: https://orcid.org/0000-0003-4205-2485)
- Kathleen Fuchs (ORCID: https://orcid.org/0009-0001-0865-0994)
- Tanya Lynn Prachar
- M. Agustina Rossetti (ORCID: https://orcid.org/0000-0003-0561-6405)
Institutions
- University of Virginia (US)
Publication Details
- Journal
- Archives of Clinical Neuropsychology
- Published
- 2024-11-28
- DOI
- https://doi.org/10.1093/arclin/acae111
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00